ABT Stock Recent News
ABT LATEST HEADLINES
US stocks are anticipated to be slow out of the blocks on Thursday as earnings emerged from PepsiCo and Abbott Laboratories, with retail sales and manufacturing surveys due. Dow Jones futures were down 0.1% and those for the S&P 500 and Nasdaq 100 were flat.
Abbott Laboratories stock falls even as the company reports second-quarter sales that top expectations.
Abbott beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its medical devices including continuous glucose monitors.
Second-quarter reported sales growth of 7.4 percent; organic sales growth of 6.9 percent or 7.5 percent excluding COVID-19 testing-related sales1 Second-quarter GAAP diluted EPS of $1.01; adjusted diluted EPS of $1.26 Reported gross margin of 52.7 percent of sales; adjusted gross margin of 57.0 percent, which reflects a 100 basis point increase Reported operating margin of 18.4 percent of sales; adjusted operating margin of 22.9 percent, which reflects a 100 basis point increase ABBOTT PARK, Ill., July 17, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2025.
Abbott Laboratories ABT will release earnings results for the second quarter, before the opening bell on Thursday, July 17.
The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports.
Abbott Laboratories (NYSE:ABT) is scheduled to announce its second-quarter earnings on Thursday, July 17, 2025. For traders who focus on events, examining the historical reactions of the stock to earnings announcements can offer useful insights.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Abbott (ABT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
Abbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments.
What's better than a great dividend? A great dividend that's growing.